Overview

• Mexico has been added to the USTR's Priority Watch List, citing unresolved issues with IP enforcement, including counterfeiting and pharmaceutical protections.
• India remains on the list due to persistent challenges such as patent revocations, long grant delays, and weak enforcement of IP rights.
• The Priority Watch List now includes eight countries: Mexico, India, China, Chile, Argentina, Indonesia, Russia, and Venezuela.
• South Korea, though not listed, was flagged for transparency concerns in pharmaceutical pricing and reimbursement policies.
• The USTR warns trading partners that failure to address IP concerns could lead to enforcement actions, including tariffs or WTO dispute proceedings.